Financials
- Market Capitalization 457 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.09
Relación precio/flujo de caja
16.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2881 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.34 USD | -4.29% | -10.07% | -25.14% | +8.94% | 462.96 M USD | ||
| 2890 | RZLT Rezolute, Inc. - Common Stock | 4.75 USD | -2.46% | +8.70% | +13.64% | -39.49% | 459.43 M USD | ||
| 2904 | ASMB Assembly Biosciences, Inc. - Common Stock | 21.95 USD | -3.60% | -2.05% | -27.58% | -25.40% | 446.92 M USD | ||
| 2906 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.70 USD | -2.30% | -7.10% | -8.60% | +6.92% | 452.48 M USD |